163Table 10.2In vivo studies and clinical trials employing human EnSCsIn vivo studiesDisease modelMode of administrationAnimal modelOutcomeReferencesCardiac regenerationDMDIntramuscularDMD mouseRecovery of dystrophin expression and subsequent muscle repair[^44]MIIntra-myocardialNude ratTransdifferentiation into cardiac cells and restoration of cardiac function[^45]MIIntra-myocardialMouseImprovement of myocardial function[^53]Neural regenerationMIIntravenousRatHoming to the injured myocardium, tissue repair and prevention of cardiac dysfunction[^54]StrokeIntracerebral, intravenousRatSignificant reduction in behavioural and histological abnormalities of stroke[^50]Pancreatic regenerationMultiple sclerosisIntraperitonealMouseReduced EAE score; upregulated levels of anti-inflammatory cytokines[^55]Parkinson’s diseaseIntrastriatalPrimateDevelopment of neuron-like morphology; expression of tyrosine hydroxylase[^56]DiabetesRenal subcapsular injectionSCID mouseBlood glucose levels were stabilized within 5 weeks[^51]DiabetesRenal subcapsular injectionSCID mouseBlood insulin levels restored with prolonged survival of graft cells[^52]Tissue engineeringScaffoldAnimal modelOutcomeReferencesGelatin-coated polyamide knitRat model of wound healing↑ Neovascularization, tissue integration, collagen fibres, distensibility of the mesh;↓chronic inflammation, fibrosis[^1]Biomimetic gelatin/apatite scaffoldsRat model of bone regeneration↑ Bone formation and maturation[^57](continued)10 Uterine Stem Cells and Their Future Therapeutic Potential in Regenerative Medicine